Lupus drug safety in pregnancy under scrutiny: new registry launches
NCT ID NCT06659029
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 30 times
Summary
This study follows 442 pregnant women with moderate-to-severe lupus to see if the drug anifrolumab affects pregnancy outcomes. Researchers will compare those who took the drug during pregnancy to those who did not. The goal is to gather safety data, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGWilmington, North Carolina, 28401, United States
Conditions
Explore the condition pages connected to this study.